Author: openjargon

A small-cap ASX miner is turning heads on Friday after releasing an update that has gone down well with the market.

At the time of writing, the Ioneer Ltd (ASX: INR) share price is up 7.14% to 15 cents.

Despite the gain, it has been a rollercoaster ride for shareholders. The stock is still down around 19% in 2026, but it has jumped 54% over the past 12 months.

The latest release seems to have hit the right note, with critical minerals still a major focus in the US.

Here’s what Ioneer announced.

Ioneer lands US Army-linked award

In a statement to the ASX, Ioneer said it received a conditional US Army award for land at Utah’s Toole Army Depot.

The company said the long-term lease would support the development of a critical mineral processing facility.

Fortunately, Ioneer was one of four companies selected, alongside Empire State Mines, EnergyX and REalloys.

The US Army is looking to use parts of its land to help build more domestic processing capacity for critical minerals. These include lithium, boron, graphite and rare earths, which are used across defence, energy and advanced manufacturing supply chains.

Ioneer said the award is tied to its Rhyolite Ridge Lithium-Boron Project in Nevada.

The company describes Rhyolite Ridge as the largest undeveloped boron ore reserve in the world outside Turkey. It also said the project is the only known lithium-boron deposit in North America.

Why this is a big deal

The land lease is useful, but this update is really about the bigger opportunity around Ioneer.

The US is trying to build more mineral processing capacity at home, especially for materials used in defence, energy and advanced manufacturing.

And this is where Rhyolite Ridge stands out.

It’s not just another lithium project. It has a large boron resource, which gives Ioneer another way into America’s supply chain push.

Boron doesn’t get mentioned as much as lithium. However, Ioneer said it is used in military armour, high-strength magnets, semiconductors and nuclear applications.

The company also noted that the US government added boron to its list of critical minerals in November 2025.

The US Army release said “The ability to process critical minerals on U.S. soil is a national-defence priority required for munitions, missiles, sensors, batteries, and the platforms our soldiers depend on.”

What investors will be watching now

While today’s update is a positive one, there is still plenty of work ahead.

Keep in mind that the lease award is conditional, and Ioneer still needs to keep moving Rhyolite Ridge toward development.

This means attention turns to progress on funding, approvals, construction plans and a final investment decision (FID).

Fortunately, there has been some progress on that front.

Recent reports have pointed to support from South Korean groups Hyundai Engineering and Korea Overseas Infrastructure & Urban Development for the project.

The post This small-cap ASX stock is soaring after a major US Army boost appeared first on The Motley Fool Australia.

More reading

• Forget PLS shares, this US-focused ASX lithium share could rise 100%+
• 5 things to watch on the ASX 200 on Thursday
• Why A2 Milk, Calix, CSL, and Ioneer shares are charging higher today
• Guess which ASX lithium share is jumping 25% on big news

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The DigiCo Infrastructure REIT (ASX: DGT) share price is in focus today after the company announced the resignation of its Chief Executive Officer, Mr Michael Juniper, effective immediately. The Board has commenced a search for a new CEO, with the existing leadership team maintaining day-to-day operations.

What did DigiCo Infrastructure REIT report?

• Mr Michael Juniper has stepped down as CEO and Director, effective 26 June 2026
• The Board is conducting a formal executive search for a permanent CEO
• The leadership team remains in place to ensure continuity
• No earnings or dividend updates were provided in this announcement

What else do investors need to know?

DigiCo Infrastructure REIT first announced Mr Juniper was on extended personal leave in March 2026. His departure marks a significant leadership transition for DGT, but the company’s strategy and ongoing operations will continue under the current management team while a successor is sought.

The Board thanked Mr Juniper for his contributions and highlighted its commitment to maintaining stability throughout the leadership transition. Both internal and external candidates will be considered for the CEO position.

What’s next for DigiCo Infrastructure REIT?

DigiCo Infrastructure REIT remains focused on executing its strategy as a diversified owner, operator and developer of data centres. The Board is prioritising a thorough CEO search process to ensure a smooth leadership transition and ongoing delivery of value for investors.

As the executive search gets underway, the existing leadership team is expected to ensure operational stability and drive the company’s plans in the short term.

DigiCo Infrastructure REIT share price snapshot

Over the past 12 months, DigiCo Infrastructure REIT shares have declined 30%, trailing the S&P/ASX 200 Index (ASX: XJO), which has risen 2% over the same period.

View Original Announcement

The post DigiCo Infrastructure REIT CEO resigns appeared first on The Motley Fool Australia.

More reading

• Centuria Capital Group opens $35m retail offer, targets growth in AI and real estate
• Transurban Group announces major North America project expansion
• Ampol launches new $400m subordinated notes facility
• 5 things to watch on the ASX 200 on Friday
• What’s next for BHP shares? Broker forecasts revealed

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Centuria Capital Group (ASX: CNI) share price is in focus today as the company opens its $35 million retail entitlement offer, following a strong $65 million institutional component and reaffirms FY26 earnings guidance.

What did Centuria Capital Group report?

• Launched a $35 million fully underwritten retail entitlement offer at $2.00 per security
• Raised $65 million from institutional investors as part of a $100 million entitlement offer
• Institutional placement raised an additional $200 million, bringing total new equity to $300 million
• FY26 operating earnings guidance reaffirmed at 13.6 cents per security, an 11.5% increase on FY25
• Offer price represents a 6.0% discount to the last close and a 5.2% discount to the adjusted TERP
• Pro-forma net asset value to rise to $1.81 per security, with pro-forma gearing reduced to 3.4%

What else do investors need to know?

The retail entitlement offer gives eligible retail investors the chance to buy 1 new Centuria security for every 17 they own, priced at $2.00 each. Investors who take up their full allocation can also apply for up to 25% more through a top-up facility, though allocations may be scaled back at the company’s discretion.

Proceeds from the $300 million total equity raising are earmarked to accelerate Centuria’s growth ambitions across both its specialist data centre platform, ResetData, and its real estate and private credit fund management business. Centuria’s recent strategic moves include scaling its Australian AI Factory capabilities and acquisition of larger real estate assets to seed new funds.

What did Centuria Capital Group management say?

Joint CEOs John McBain and Jason Huljich commented:

The Centuria and ResetData combination has created a differentiated NVIDIA neocloud partner with scalable sovereign AI Factories and access to Centuria’s real estate, land and potential 200MW+ power pipeline. ResetData is one of three Australian NVIDIA Cloud Partners and is uniquely placed to take advantage of an upswing in international demand for the establishment of Australian-based AI Factory capacity uptake.

What’s next for Centuria Capital Group?

Looking ahead, Centuria will focus on deploying new funds into its ResetData pipeline, targeting accelerated development of AI Factory data centres and onboarding enterprise and government customers seeking sovereign compute capacity. Further growth is expected as Centuria expands its credit funds management and continues scaling up its real estate platform with larger fund launches and property acquisitions.

Management reconfirmed its disciplined approach to capital allocation and flagged balance sheet flexibility will support future organic and inorganic growth opportunities, while the new securities will rank equally with existing ones (except for the June 2026 distribution).

Centuria Capital Group share price snapshot

Over the past 12 months, Centuria Capital Group shares have risen 16%, outperforming the S&P/ASX 200 Index (ASX: XJO), which has risen 2% over the same period.

View Original Announcement

The post Centuria Capital Group opens $35m retail offer, targets growth in AI and real estate appeared first on The Motley Fool Australia.

More reading

• Transurban Group announces major North America project expansion
• Ampol launches new $400m subordinated notes facility
• 5 things to watch on the ASX 200 on Friday
• What’s next for BHP shares? Broker forecasts revealed
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Sorry.

Yesterday, I emailed you to let you know I was going to hold a YouTube LIVE today at midday, AEST.

And then the emails started coming in.

Apparently there’s a soccer game or something at the same time…

I jest… there is a very important World Cup game at midday between the Socceroos and Paraguay.

Naively, I knew the game was on today, but I didn’t check the time. Our last game was at 5am AEST, and it didn’t occur to me that today’s game would be at midday.

I should have checked. As they say, you know what happens when you assume.

So… please accept my apologies for the false start. We’ll reschedule.

But it won’t be for a few weeks.

The reason is that I’m taking some annual leave.

As I do pretty regularly at this time of year, we’re about to kick off a family road trip, this time heading up to Cape York.

We’re spending three weeks doing the loop from Cairns to The Tip (the northern-most point of mainland Australia) and back.

What about the investment services I work on? What about my portfolio?

Good questions.

If you’re a Motley Fool member, please know that we have a strong team in place, and you’ll see no impact on your membership or the delivery of content.

Also, we’re long term investors.

Sure, there’s a chance that at some point while I’m away, there’ll be some news that does impact our view on a recommendation.

And if that happens, our team will evaluate the new information (and I’ll be contactable while I’m away, if they need me).

But the odds of that are pretty low.

Share prices might move… but they always do.

Sentiment might change… but it always does.

Will things happen that change our expectation of the long-term prospects of the companies we’ve recommended you own?

That’s far, far less likely.

Which is also precisely why I’m not doing anything to my portfolio before I leave.

Because yes, share prices might fall.

But also, they might rise.

News could be bad.

Or it could be good.

And remember… over time economies tend to grow, profits tend to rise, dividends tend to rise and share prices tend to rise.

The next few weeks will be me walking the talk.

I write – and yes, talk – regularly about long-term investing. About buying quality companies at decent prices, and letting time do the work.

If you’re a sceptical person, you might think ‘well, it’s fine for you to say that, but what happens when the rubber hits the road?’.

And the next few weeks will be exactly that.

Not only literally – we’ll be doing quite a few miles – but metaphorically, because you’ll see me living that approach in real time.

I suspect you’ll probably hear from me while I’m away, too. No promises – and I’ll try to avoid sporting events! – because it’s a family holiday and I want to be present.

But I’m often up earlier or killing some time while the family is doing other things. So if I have the chance, and have the inspiration, I might just pop up here, while I’m away.

A few weeks feels like a long time, when you’re going through it.

When prices are volatile, when headlines are shouting, when talking heads are prognosticating, and when politicians are doing, well, politician things, a day can feel like a week and a week can feel like a month.

But I took a similar holiday at this time last year. Do you remember what happened during that time? I didn’t think so. Me either.

The year before? The year before that?

Exactly.

It can be really hard to keep perspective at the time, but I find it helpful to think back to those times to remind myself to not get caught up in short-term volatility.

The market might be higher when I get back. Or lower.

My portfolio might be larger… or smaller.

My recommendations might be worth more… or less.

But my – or your – presence or absence won’t change that.

That’s the key lesson.

(And go the Socceroos!)

Fool on!

The post Don’t watch me… watch the Socceroos! appeared first on The Motley Fool Australia.

More reading

• Centuria Capital Group opens $35m retail offer, targets growth in AI and real estate
• Transurban Group announces major North America project expansion
• Ampol launches new $400m subordinated notes facility
• This ASX 200 stock has soared 1,800%. Is there more to come?
• Bell Potter is tipping this ASX energy stock to rise 40% (It isn’t Woodside)

Motley Fool contributor Scott Phillips has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Transurban Group (ASX: TCL) share price is in focus today after announcing a major expansion to its North American operations, including a proposed 140% capacity boost for the I-95 Express Lanes.

What did Transurban report?

• Entered a Development Framework Agreement for enhanced Bi-Directional Project on I-95 Express Lanes in Virginia
• Transurban holds 50% indirect interest in the 95 Express Lanes LLC
• Proposed project scope would add about 120 new lane miles—six times more than previously planned
• 10-mile extension will extend the lanes through Fredericksburg into Spotsylvania County
• Project would increase I-95 Express Lanes capacity by around 140%
• Financial close is targeted for 2029, subject to agreement and approval

What else do investors need to know?

The development marks a major step in Transurban’s North American growth strategy, demonstrating the company’s ability to secure significant infrastructure opportunities in markets it knows well. The collaboration with the Virginia Department of Transportation is expected to bring benefits to both local motorists and Transurban stakeholders.

The next stage will focus on final design work, contractor selection, and confirming capital requirements, ahead of submitting a binding proposal. Transurban anticipates further updates as the project advances, reinforcing its long-term presence and partnerships in the US market.

What did Transurban management say?

Transurban CEO Michelle Jablko said:

Opportunities of this scale in a market we know well, underscore the strength and optionality of Transurban’s North American presence, as we continue to partner with government to deliver transformative infrastructure that drives long-term value for both customers and our investors.

What’s next for Transurban?

With the expanded project scope, Transurban is positioned to play a key role in upgrading one of the region’s most important transport corridors. Management expects the proposed I-95 project to deliver growth potential, customer benefits, and ongoing value for investors.

Transurban will now work on design, contractor engagement, and final cost estimates before progressing to the next stage. If the binding proposal gains approval, financial close is targeted for 2029.

Transurban share price snapshot

Over the past 12 months, Transurban shares have risen 9%, outperforming the S&P/ASX 200 Index (ASX: XJO), which has risen 2% over the same period.

View Original Announcement

The post Transurban Group announces major North America project expansion appeared first on The Motley Fool Australia.

More reading

• Centuria Capital Group opens $35m retail offer, targets growth in AI and real estate
• Ampol launches new $400m subordinated notes facility
• 5 things to watch on the ASX 200 on Friday
• What’s next for BHP shares? Broker forecasts revealed
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Transurban Group. The Motley Fool Australia has positions in and has recommended Transurban Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Ampol Ltd (ASX: ALD) share price is in focus today after the company announced a new A$400 million delayed-draw subordinated notes facility, following successful previous issues in 2025. This new facility supports Ampol’s ongoing capital management and provides flexible, long-term funding options.

What did Ampol report?

• Launched a wholesale offer of a new A$400 million delayed-draw subordinated notes facility
• Facility can be drawn in two tranches: A$250 million and A$150 million
• ~9-month and ~24-month availability periods for the two tranches, respectively
• 12-year non-call period and a final maturity in 2058
• Net proceeds earmarked to refinance existing subordinated notes callable in 2027 and 2028
• Facility fully underwritten by a cornerstone institutional investor group

What else do investors need to know?

The delayed-draw feature means Ampol can access funding flexibly as needed, with the option to issue the facility in two parts and the right to cancel the second tranche if desired. The subordinated notes are structured to secure long-term capital at fixed pricing, supporting stability in Ampol’s future refinancing plans.

Moody’s Investors Service is expected to assign 50% equity credit to the new notes, in line with Ampol’s existing subordinated debt. The offer is targeted only at institutional investors, with a closing date around 9 July 2026, subject to typical conditions.

What did Ampol management say?

Group Chief Financial Officer Greg Barnes said:

We’re delighted to announce this new financing facility, which utilises the same delayed-draw feature from our previous issue in December 2025. Investor commitments and issue pricing will be fixed upfront. Market conditions remain attractive and provide an opportune time to secure long-term capital, which is linked to our future hybrid refinancing initiatives. The delayed-draw feature gives Ampol significant flexibility with regards to issue timing, as well as use of proceeds and cancellation rights. The transaction is another example of our proactive approach to capital management.

What’s next for Ampol?

Ampol plans to use the facility to proactively refinance subordinated notes due in 2027 and 2028, aiming to optimise its balance sheet and preserve flexibility for future funding needs. Management is focused on securing stable, long-term capital to support its ongoing growth and sustainability initiatives, while enhancing its capital management strategy.

Ampol share price snapshot

Over the past 12 months, Ampol shares have risen 29%, outperforming the S&P/ASX 200 Index (ASX: XJO), which has risen 2% over the same period.

View Original Announcement

The post Ampol launches new $400m subordinated notes facility appeared first on The Motley Fool Australia.

More reading

• Centuria Capital Group opens $35m retail offer, targets growth in AI and real estate
• Transurban Group announces major North America project expansion
• 5 things to watch on the ASX 200 on Friday
• What’s next for BHP shares? Broker forecasts revealed
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

It has been another big day for 4DMedical Ltd (ASX: 4DX) shareholders.

The ASX 200 healthcare stock is pushing higher on Friday after releasing an update that has kept investors interested.

At the time of writing, the 4DMedical share price is up 8.75% to $4.97.

The stock is now up around 40% over the past month and an incredible 1,800% since this time last year.

Here’s what 4DMedical announced to the market.

4DMedical gets TGA approval

According to the release, 4DMedical has received approval from the Therapeutic Goods Administration (TGA) for its CT:VQ product in Australia.

This means CT:VQ has now been included on the Australian Register of Therapeutic Goods, allowing it to be sold commercially across the country.

The company said CT:VQ is the world’s first non-contrast, CT-based ventilation-perfusion imaging solution.

The software helps doctors see how air and blood move through the lungs using standard CT scans. Essentially, patients can be assessed without the need for some nuclear medicine imaging methods.

4DMedical said the approval could support use across metropolitan, regional, and rural Australia, including areas with CT scanners but limited access to nuclear medicine services.

The company noted that CT:VQ is already approved in several major markets, including the US, Europe, the UK, Canada, and New Zealand.

What investors will be watching now

The approval gives 4DMedical a new market to work with, but investors will want to see how quickly that turns into adoption.

Although, there’s already some progress overseas.

In the United States, CT:VQ has been deployed at major clinical sites including Stanford, Cleveland Clinic, and the University of Miami.

The company has also signed an agreement with SimonMed Imaging, one of the largest outpatient radiology providers in the United States.

Back in Australia, the next step for the company is reimbursement.

Management said it is preparing an application to the Medical Services Advisory Committee to seek future Medicare Benefits Schedule reimbursement for CT.

If that’s approved, it could make the product much easier to be used more widely across our healthcare system.

Can the rally keep going?

Without doubt, the approval is a positive milestone.

But after rocketing 1,800% in 12 months, this isn’t a small company anymore flying under the radar.

4DMedical has a market capitalisation of around $2.8 billion, which means investors are already pricing in a much larger business.

And while that doesn’t mean the rally has gone too far, it certainly does raise the bar.

For now, the company needs to keep showing that CT can move from approvals and trial sites into broader commercial use.

The post This ASX 200 stock has soared 1,800%. Is there more to come? appeared first on The Motley Fool Australia.

More reading

• This ASX healthcare stock is up 1,900%. One top fundie wants more
• Up 1,700% and more, what’s next for these ASX 200 shares?
• Here are the top 10 ASX 200 shares today
• Here are the 10 most shorted ASX shares
• Healthcare shares led the ASX 200 last week. Is a sector comeback underway?

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

When it comes to investing in the energy sector, Santos Ltd (ASX: STO) and Woodside Energy Group Ltd (ASX: WDS) shares are often front of mind.

But there is another ASX energy stock that Bell Potter is recommending to shareholders.

Which ASX energy stock?

The stock Bell Potter is bullish on is Comet Ridge Ltd (ASX: COI).

It is an energy exploration and development company focused on the Mahalo Gas Hub in Queensland’s Bowen Basin.

Bell Potter notes that the company is raising up to $45 million. These funds will be used partly to settle its acquisition of Santos’ 42.86% interest in the Mahalo joint venture.

The broker highlights that this leaves it well-placed now to focus on its final investment decision (FID), which is due in FY 2027. It said:

COI is now targeting Gas Sales Agreements and releasing Mahalo Gas Project economics by the end of 2026 to support funding approvals and a Final Investment Decision by the end of the March 2027 quarter. On this timeline, COI see first gas production in late 2028.

The Mahalo development will leverage 676PJ of 2P Reserves plus 2C Contingent Resources, successful pilot wells and the permitting already received over some acreage. With the STO transaction now funded, COI must now turn its efforts to funding Mahalo’s development capital costs, the quantum of which will be highly dependent on the development scenarios and project economics now being considered.

Should you invest?

According to the note, Bell Potter has retained its speculative buy rating on the ASX energy stock with a reduced price target of 14 cents.

Based on its current share price of 9.9 cents, this implies potential upside of 41% for investors over the next 12 months.

To put that into context, a $2,000 investment would turn into approximately $2,800 by this time next year if the broker is on the money with its recommendation.

Commenting on its investment thesis, Bell Potter said:

Our COI valuation is based on COI’s Mahalo project which is one of the few development-ready gas projects capable of delivering near-term supply. We are positive on Australian east coast gas markets, with supply shortfalls likely to support higher prices. Funding the Mahalo development remains a risk. COI is a gas development company with prospective operations and cash flows only; our Speculative risk rating recognises this higher level of risk.

The post Bell Potter is tipping this ASX energy stock to rise 40% (It isn’t Woodside) appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Friday
• Crude oil falls below US$70 as ASX energy shares sell-off
• Why Judo Capital, Minerals 260, Santos, and Worley shares are dropping today
• Is the Woodside share price a buy in July?
• 5 things to watch on the ASX 200 on Thursday

Motley Fool contributor James Mickleboro has positions in Woodside Energy Group Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The team at Bell Potter has identified an ASX 200 share that they believe could generate big returns for investors.

And while no dividend is expected in 2026, it could pay to be patient, with the broker expecting a big dividend yield next year.

Which ASX 200 share?

The share that has caught the eye of Bell Potter is Nickel Industries Ltd (ASX: NIC).

It notes that the nickel producer has announced deals to acquire more production capacity. It said:

NIC has announced it will acquire interests in expansions to the existing ENC HPAL facility (46% NIC) which will lift its attributable nickel in HPAL capacity by ~17ktpa (41%) to 58.6ktpa. NIC will acquire a 17.5% interest in the 36ktpa PT Teluk Metal Industry (TMI) expansion for US$169m cash consideration. Separately, NIC will acquire a 36% interest in the 28ktpa PT Chengsheng New Energy (CNE) expansion via an equity swap with consideration being an 18% interest in the Sampala Project (reducing NIC from 60% to 42%). TMI and CNE are both expected to come online in mid-2027 with ore supply from Sampala.

The TMI acquisition is subject to a Construction Guarantee capping the acquisition cost at US$169m and delivery of nameplate production by September 2027. NIC expects to fund the cash payment, due 26 November 2026, from existing cash and operating cash flow. If needed, NIC’s major shareholder (Shanghai Decent) will provide debt funding on commercial terms. NIC held cash and equivalents of US$212m at end March 2026.

Big potential returns

According to the note, Bell Potter has retained its buy rating on the ASX 200 share with an improved price target of $1.55 (from $1.45).

Based on its current share price of 89 cents, this implies potential upside of almost 75% for investors over the next 12 months.

And as mentioned at the top, no dividend is expected in FY 2026. However, in FY 2027 an unfranked 6 cents per share dividend is forecast, followed by a 14 cents per share dividend in FY 2028.

This implies potential dividend yields of 6.75% and 15.7%, respectively.

Commenting on its buy recommendation, Bell Potter said:

EPS changes in this report are: CY26: +1%, CY27 +5%, CY28 +16%. NIC offers nickel price leverage and diversified margin exposure across an integrated value chain. The HPAL expansion transactions will further balance NIC’s earnings into downstream higher-margin operations and preserve earnings through the nickel price cycle. We lift our Target Price 7% to $1.55/sh and retain our Buy rating.

The post Should you buy this ASX 200 share for its 15% forecast dividend yield? appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Friday
• This ASX 200 stock is up almost 30% in a year. Now it is making another big move
• Nickel Industries shares: US$169m TMI HPAL investment boost
• This ASX 200 mining stock is up 44% in a year. Why is it climbing again?
• Why AIC Mines, EOS, Flight Centre, and Nickel Industries shares are racing higher today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

EchoIQ Ltd (ASX: EIQ) shares were on fire on Friday.

The ASX tech stock rocketed 30% to $1.62 after Pro Medicus Ltd (ASX: PME) announced a major investment in the company and a marketing agreement.

The market appears to see this investment as a stamp of approval from the medical imaging technology provider.

Pro Medicus’ CEO, Dr Sam Hupert, commented:

In addition to providing financial backing, we are looking to offer our Visage 7 Cardiology customers the option of Echo IQ’s technology. This is in line with our AI strategy of offering a curated suite of algorithms that will be a mixture of algorithms created by us, those created in conjunction with our clinical partners and 3rd party algorithms such as Echo-IQ.

Is it too late to buy this ASX tech stock?

The good news is that Bell Potter doesn’t believe it is too late to buy this high-flying share. However, the near-term upside from here could be limited.

According to a note, the broker has initiated coverage on the cardiology-focused medical technology company’s shares with a speculative buy rating and $1.65 price target. This is just a fraction higher than where its shares currently trade.

Bell Potter believes there is a major unmet need that the ASX tech stock could help with. It explains:

The major unmet need in this patient population are those currently asymptomatic (i.e. without obvious symptoms) with severe disease. The vast majority proceed to symptomatic disease within two years and become candidates for aortic value replacement. Recent clinical data has proven that early intervention drives a significant survival benefit.

The data suggest that the majority of these patients are not identified using current screening methods and fewer still receive treatment. Finally, this recent clinical data has been recognised by CMS which recently proposed an update to its National Coverage Determination to extend reimbursement for AS patients with asymptomatic disease.

Commenting on its speculative buy rating, Bell Potter adds:

We commence coverage with a Buy (Speculative) recommendation and valuation of $1.65. We expect EIQ expand rapidly over the short to medium term as healthcare operators and payers recognise the benefit of these diagnostic aides in helping to minimise the long term cost of heart failure to US healthcare.

Overall, this could make it one to watch in the near term.

The post Is this exciting ASX tech stock a buy after its massive news? appeared first on The Motley Fool Australia.

More reading

• Pro Medicus just struck a revolutionary AI cardiology deal. Here’s why that matters
• Why is everyone talking about Mineral Resources, A2 Milk and Pro Medicus shares on Thursday?
• Why A2 Milk, EchoIQ, Lendlease, and Qantas shares are racing higher today
• A deal with Pro Medicus has turned this ASX biotech into a 10-bagger, up more than 30% today
• Pro Medicus shares jump again as AI deal adds fuel to 40% rally

Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.